Abionic Successfully Raises CHF20 Million in Series C Financing

• Network of Eminent High Net Worth Individuals Join Financing Syndicate • Financing to Extend Abionic’s Portfolio of Point-of-Care IVD Tests for Critical Care and Emergency Medicine • International Clinical Study of World’s Most Rapid Sepsis Test Starts in 14 Hospitals Biopôle, Lausanne, Switzerland, March 28, 2018 Abionic SA, a developer of disruptive nanotechnology based [...]

By |2018-04-06T17:20:46+00:00 Friday, 6 April, 2018|Press Releases|0 Comments

Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors

• Former Roche Diagnostics CSO, Gerd Grenner and Biocartis Co-Founder Nader Donzel Join Board as Independent Members Biopôle, Lausanne, Switzerland, December 6, 2017 Abionic SA, a developer of disrupter nanotechnology based rapid diagnostic solutions, announced today the appointment of two diagnostic industry experts, Dr. Gerd Grenner and Nader Donzel, to its Board of Directors. “As [...]

By |2017-12-06T09:05:46+00:00 Wednesday, 6 December, 2017|Press Releases|0 Comments

Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE® Diagnostic Testing Platform

• Test detects sensitization to four common respiratory allergens in United States • Scheduled to be commercially available in the US in 2018 Lausanne, Switzerland, October 20, 2017 Abionic SA, a developer of disrupter nanotechnology based rapid diagnostic solutions, announced today that its rapid allergy test, IVD CAPSULE Aeroallergens, and the easy to use testing [...]

By |2017-10-20T09:45:13+00:00 Friday, 20 October, 2017|Press Releases|0 Comments

Sepsis diagnostics: Abionic to improve early diagnosis of sepsis and treatment management

World Sepsis Day 2017 – Abionic to mprove early diagnosis of sepsis and treatment management. • World Sepsis Day is celebrated worldwide on September 13, 2017. • World Sepsis Day is celebrated worldwide on September 13, 2017. • Without adequate antibiotics treatment, the future of sepsis care would be alarming. • CE marked abioSCOPE PSP [...]

By |2017-10-02T17:30:35+00:00 Wednesday, 13 September, 2017|Press Releases, Sepsis|0 Comments

World’s Fastest Sepsis Test from Abionic Produces Result in Five Minutes when Tested in patients at London and Zurich Hospitals

• The UK National Institute for Health and Care Excellence (NICE) is urging hospital staff to treat people with life-threatning sepsis symptoms within one hour • University College London Hospitals (UCLH) evaluation highlighted that the 5 minutes abioSCOPE is perfectly adapted for use as a near-patient testing platform for accelerating time to results in hospitals [...]

By |2017-10-02T17:31:52+00:00 Wednesday, 7 June, 2017|Press Releases, Sepsis|0 Comments

Abionic décroche deux nouvelles reconnaissances : les SEF High Potential & Finance Monthly Game Changers Awards

• Abionic obtient aujourd’hui la certification par le label SEF High potential, ce qui confirme la qualité et le potentiel de son appareil de diagnostic ultra-rapide ; • Abionic reçoit également le prix Finance Monthly Game Changers en reconnaissance de son modèle d’affaire qui a le potentiel de changer le monde. Epalinges, Suisse, le 10 [...]

By |2017-02-24T14:43:12+00:00 Friday, 10 February, 2017|Press Releases|0 Comments

Sepsis diagnostics: Abionic Receives CE Mark for Most Rapid Sepsis and Iron Deficiency Point of Care Diagnostics

• Test to help assess the risk of sepsis in ER’s and ICU’s available for sale in 2018 • Screening test for iron deficiency available through pharmacies and GPs in first half 2017. Lausanne, Suisse, January 9th 2017 Abionic SA, a developer of disrupter nanotechnology based point-of-care diagnostic solutions, announced today the receipt of CE [...]

By |2017-10-02T17:05:21+00:00 Monday, 9 January, 2017|Press Releases|0 Comments